This is our library on scientific research related to CBD, the Endocannabinoid System, other cannabinoids and Osteoporosis – Bone Health. Below you will find a list of conditions for which there are one or more scientific studies of CBD. The source of these scientific studies relates primarily to PubMed, an online service of the U.S. National Library of Medicine.
Important: The studies that are listed by PubMed are for the most part preclinical research. These relate in most cases to animal experiments with isolated CBD (pure CBD) and not fully extracted CBD extract. Although mammals have cell receptors that respond to cannabinoid compounds, the data collected from animal studies are not always 1: 1 applicable to humans. Always check with your physician before starting a new dietary supplement program. Learn more at The Basics of CBD Oils and Cannabis as a Therapeutic Agent
- Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells
- Cannabinoid receptors and the regulation of bone mass
- Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies
- Cannabinoids and bone: Friend or foe?
- Cannabinoids and the skeleton: From marijuana to reversal of bone loss
- CBD Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts
- Endocannabinoids and the regulation of bone metabolism
- Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis
- Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health
- Peripheral cannabinoid receptor, CB2, regulates bone mass
- Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
- Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family
- The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
- The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy